One anastomosis gastric bypass as a primary bariatric surgery: MBSAQIP database analysis of short-term safety and outcomes
- PMID: 37989890
- DOI: 10.1007/s00464-023-10535-7
One anastomosis gastric bypass as a primary bariatric surgery: MBSAQIP database analysis of short-term safety and outcomes
Abstract
Background: One anastomosis gastric bypass (OAGB) is described as a simpler, potentially safe, and effective bariatric-metabolic procedure that has been recently endorsed by the American Society of Metabolic and Bariatric Surgery.
Objectives: First, we aim to compare the 30-day outcomes between OAGB and other bypass procedures: Roux-en-Y gastric bypass (RYGB) and single anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S). Second, identify the odds between postoperative complications and each surgical procedure.
Methods: Patients who underwent primary OAGB, RYGB, and SADI-S were identified using the MBSAQIP database of 2020 and 2021. An analysis of patient demographics and 30-day outcomes were compared between these three bypass procedures. In addition, a multilogistic regression for overall complications, blood transfusions, unplanned ICU admissions, readmission, reoperation, and anastomotic leak stratified by surgical procedure was performed.
Results: 1607 primary OAGBs were reported between 2020 and 2021. In terms of patient demographics, patients who underwent RYGB and SADI-S showed a higher incidence of comorbidities. On the other hand, OAGB had shorter length of stay (1.39 ± 1.10 days vs 1.62 ± 1.42 days and 1.90 ± 2.04 days) and operative times (98.79 ± 52.76 min vs 125.91 ± 57.76 min and 139.85 ± 59.20 min) than RYGB and SADI-S. Similarly, OAGB showed lower rates of overall complications (1.9% vs 4.5% and 6.4%), blood transfusions (0.4% vs 1.1% and 1.8%), unplanned ICU admission (0.3% vs 0.8% and 1.4%), readmission (2.4% vs 4.9% and 5.0%), and reoperation (1.2% vs 1.9% and 3.1%). A multilogistic regression analysis was performed, RYGB and SADI-S demonstrated higher odds of 30-day complications.
Conclusion: The incidence of primary OAGB has increased since its approval by ASMBS, from 0.05% reported between 2015 and 2019 to 0.78% between 2020 and 2021. OAGB had better 30-day outcomes and shorter operative times than RYGB and SADI-S and therefore, could be considered a viable alternative.
Keywords: One anastomosis gastric bypass; Outcomes; Roux-en-Y gastric bypass; Single anastomosis duodenoileal bypass.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Haddad A, Bashir A, Fobi M, Higa K, Herrera MF, Torres AJ, Himpens J, Shikora S, Ramos AC, Kow L, Nimeri AA (2021) The IFSO Worldwide One Anastomosis Gastric Bypass Survey: techniques and outcomes? Obes Surg 31:1411–1421. https://doi.org/10.1007/s11695-021-05249-5 - DOI - PubMed
-
- Mason EE, Ito C (1967) Gastric bypass in obesity. Surg Clin N Am 47:1345–1351. https://doi.org/10.1016/s0039-6109(16)38384-0 - DOI - PubMed
-
- Ramos A, Kow L, Brown W, Welbourn R, Dixon J, Kinsman R, Walton P (2019) Fifth IFSO Global registry report 2019. https://www.ifso.com/pdf/5th-ifso-global-registry-report-september-2019.pdf . Accessed 02 Oct 2023
-
- ASMBS (2019) ASMBS endorsed procedures and FDA approved devices. https://asmbs.org/resources/endorsed-procedures-and-devices . Accessed 27 Mar 2019
-
- Jung JJ, Park AK, Hutter MM (2022) The United States experience with one anastomosis gastric bypass at MBSAQIP-accredited centers. Obes Surg 32:3239–3247. https://doi.org/10.1007/s11695-022-06002-2 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
